New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

ETF What's Up

Don’t Miss a Move in the ETF Market

Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.

ETF What's Up

You may unsubscribe at any time by clicking the “unsubscribe” link within the emailed newsletter. By signing up, you agree to our Privacy Policy and Terms and Conditions.

ETF IssuersiSharesXHC
XHC

iShares Global Healthcare Index ETF

The XHC Exchange Traded Fund (ETF) is provided by iShares. It is built to track an index: S&P Global 1200 Healthcare Index. This share class generates a stream of income by distributing dividends.

$70.90
-$0.92 (-1.28%) today
1:30 PM 07/20/26 Closed
1D price range
$70.90$71.40
52W price range
$60.53$73.39
YTD Perf.
+2.49%
YTD Flows
Annualized volatility
Fund AuM
€323M
Share class AuM
€323M
TTM Yield
Tracking Error
Tracking Difference
ISIN
CA46431R1029
TER
0.66%
Inception date
4/12/2011
Issuer
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Jul 17, 2026
-8%-6%-4%-2%0%2%4%6%JANMARMAYJUL
Flows
Join for free to unlock
Data as of 05/31/26
Healthcare
96.69%
Consumer Non-Cyclicals
1.52%
Unavailable
0.70%
Other
1.03%
Latest XHC news

No content available for this fund

FAQ about XHC

XHC is a Passive ETF. This ETF provides exposure to Large Cap Global Health Care Equities.
XHC tracks the S&P Global 1200 Health Care CAD Hedged Net Total Return Index - CAD, through a replication method.
XHC carries a total expense ratio (TER) of 0.66%, indicating the annual cost for holding the fund.
XHC was introduced to the market on April 12, 2011. It trades on Canada
iShares Global Healthcare Index ETF, XHC, is provided by iShares. Learn more about iShares here.
XHC oversees €323M in assets as of July 17, 2026.
XHC follows a distributing dividend policy, meaning it pays out income to investors. As of July 17, 2026, its 12-month trailing yield was 1.89%.
As of May 31, 2026, XHC has significant geographic allocations in USA, Switzerland and United Kingdom.
As of May 31, 2026, XHC focuses largely on Healthcare and Consumer Non-Cyclicals.
As of May 31, 2026, XHC holds 114 positions in its portfolio, with 57.70% of assets concentrated in its top 15 holdings.
As of May 31, 2026, XHC top three holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
The base currency of XHC is CAD.
XHC is hedged, meaning it seeks to minimize the impact of currency fluctuations between its base currency and the currency of the underlying assets.
Data as of 05/31/26
Eli Lilly & Co.
11.22%
Johnson & Johnson
6.96%
AbbVie, Inc.
4.93%
UnitedHealth Group, Inc.
4.52%
Roche Holding AG
3.88%
Merck & Co., Inc.
3.86%
AstraZeneca PLC
3.78%
Novartis AG
3.76%
Thermo Fisher Scientific, Inc.
2.43%
Amgen, Inc.
2.38%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight